| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 20 |
| 1 | EVEROLIMUS | 9 |
| 2 | CAPECITABINE | 6 |
| 3 | TEMOZOLOMIDE | 6 |
| 4 | CARBOPLATIN | 5 |
| 5 | ETOPOSIDE | 5 |
| 6 | TELOTRISTAT ETHYL | 4 |
| 7 | WARFARIN | 3 |
| 8 | CALCIUM | 2 |
| 9 | HYDROCHLOROTHIAZIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 1 | 0.0033 |
| 1 | OCTREOTIDE ACETATE | 20 | 0.0009 |
| 2 | TELOTRISTAT ETHYL | 4 | 0.0008 |
| 3 | PAMIDRONATE DISODIUM | 2 | 0.0007 |
| 4 | TEMOZOLOMIDE | 6 | 0.0005 |
| 5 | FOSINOPRIL | 1 | 0.0003 |
| 6 | EVEROLIMUS | 9 | 0.0002 |
| 7 | DICLOFENAC SODIUM AND MISOPROSTOL | 1 | 0.0002 |
| 8 | LOPERAMIDE HCL | 1 | 0.0002 |
| 9 | ETOPOSIDE | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 9 |
| 1 | mTOR Inhibitor Immunosuppressant [EPC] | 9 |
| 2 | Alkylating Drug [EPC] | 6 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 4 | Platinum-based Drug [EPC] | 5 |
| 5 | Topoisomerase Inhibitor [EPC] | 5 |
| 6 | Calcium [EPC] | 2 |
| 7 | Phosphate Binder [EPC] | 2 |
| 8 | Thiazide Diuretic [EPC] | 2 |
| 9 | Aluminum Complex [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 2 | Aluminum Complex [EPC] | 1 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 6 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 9 | 0.0000 |
| 8 | Anti-IgE [EPC] | 1 | 0.0000 |
| 9 | Calcium [EPC] | 2 | 0.0000 |